Evidence map›Paper›PMID 42686793›Full record

ArticleScientific reports2026

Assessing China's COVID-19 control measures: a quantitative analysis based on a SIRD model.

Yan Wu, Ming Yi, Daojun Bi, Hongzhong Fan

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yan WuSchool of Economics, Huazhong University of Science and Technology, Wu han, Hubei Province, China. ywu2019@126.com.
Ming YiSchool of Economics, Huazhong University of Science and Technology, Wu han, Hubei Province, China.
Daojun BiSchool of Business, Xinyang Normal University, Xinyang, He Nan Province, China.
Hongzhong FanSchool of Economics, Huazhong University of Science and Technology, Wu han, Hubei Province, China.

Funding

The 2024 Henan Provincial Philosophy and Social Sciences Planning Project 2024CJJ157the National Natural Science Foundation 71801102
6 · The paper itself

Abstract

This paper established a Susceptible-Infected-Recovered-Dead (SIRD) model to fit and predict the COVID-19 epidemic in China. On the premise of passing the Markov Chain Monte Carlo (MCMC) robustness check, we counterfactually assessed the effectiveness of partial unlocking and vaccination policies. Our key findings are as follows: (1) The SIRD model predicted that China could fully contain COVID-19 in July, 2020, which is consistent with reality; (2) If the strict social distancing policies are relaxed before the epidemic ends, it will lead to a second rebound. Even worse, the rebound increases with the advance of relaxation time and relaxation degree; (3) Timely vaccination is the best strategy if it is available. However, delayed vaccination is much less effective. (4) When further taking natural population growth rates into account, we find that the principal conclusions remain robust. The inclusion of demographic dynamics helps mitigate potential fitting bias resulting from changes in population size over extended epidemic periods like the COVID-19 pandemic. Empirically, the model shows a certain degree of applicability in regions with similar transmission trends. This paper theoretically and quantitatively supports the view that the effectiveness of China's comprehensive prevention and control measures, and empirically verifies that the model has potential reference significance for some regions with similar transmission trends.

Indexed as

COVID-19PandemicsChinaEpidemiological ModelsHumansMarkov ChainsMonte Carlo MethodSARS-CoV-2VaccinationCOVID-19Natural population growth ratePartial lockdownSIRD modelSocial distancingVaccination

Identifiers

PMID42686793
PMCPMC13538384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.